D, P., C, J., K, H., R, V., F, H., P, L. C., . . . E, B. (2025). Correction to: The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia. Advances in therapy, 42(11), 5854. https://doi.org/10.1007/s12325-025-03371-9
Chicago Style (17th ed.) CitationD, Price, et al. "Correction to: The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia." Advances in Therapy 42, no. 11 (2025): 5854. https://doi.org/10.1007/s12325-025-03371-9.
MLA (9th ed.) CitationD, Price, et al. "Correction to: The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia." Advances in Therapy, vol. 42, no. 11, 2025, p. 5854, https://doi.org/10.1007/s12325-025-03371-9.